Paediatric

By Sébastien Croquet, Global Technical Applications Specialist, Roquette’s Health and Pharma Solutions Stephen Flynn, Global Product Marketing Leader, Polyols, Roquette’s...

Abstract Purpose Lamotrigine therapy in pediatric epilepsy is constrained by the absence of age-appropriate dosage forms, as commercially available tablets...

Introduction Paediatric patients require age-appropriate oral dosage forms with flexible dosing and good acceptability. Conventional paediatric formulations may require manipulation,...

Abstract Background/Objectives: Scabies is a disease that disproportionately affects young children. Oral ivermectin is a mainstay of scabies therapy, yet...

Abstract Although solid oral dosage forms are widely used in adult drug therapy, age-appropriate formulations for pediatric patients remain limited....

Abstract In the pediatric patient group, there is a constant need for individualized dosage forms with precise and adjustable drug...

Abstract The lack of age-appropriate dosage forms forces a heavy reliance on pediatric extemporaneous compounding, increasing risks of excipient-related toxicity...

Abstract In vitro compatibility assessments are a valuable tool for the early identification of potential drug–vehicle interactions. To standardize such evaluations,...

Abstract BACKGROUND The pediatric drug development landscape has experienced major shifts, largely in response to legislative and regulatory initiatives. However,...

Introduction The primary reason children refuse medicine is taste. Bitterness, astringency, and metallic aftertaste cause patients to stop taking their...